I-ABA
|
I610898-25mg
|
Moligand™ |
98866-49-0 |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
IAA-94
|
I610897-5mg
|
Moligand™ |
53108-00-2 |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
IAA-94
|
I610897-25mg
|
Moligand™ |
53108-00-2 |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
I-432
|
I610896-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
I-432
|
I610896-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
I3MT-3
|
I610895-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
I3MT-3
|
I610895-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
I-287
|
I610894-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
I-287
|
I610894-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
I-191
|
I610893-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
I-191
|
I610893-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
2-(3-(1-((4′-Isopropyl-[1,1′-biphenyl]-3-yl)sulfonyl)piperidin-3-yl)phenoxy)-2-methyl-N-((4-(trifluoromethyl)phenyl)sulfonyl)propanamide
|
I609222-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
2-(3-(1-((4′-Isopropyl-[1,1′-biphenyl]-3-yl)sulfonyl)piperidin-3-yl)phenoxy)-2-methyl-N-((4-(trifluoromethyl)phenyl)sulfonyl)propanamide
|
I609222-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-N-[3-imidazol-1-yl-5-(trifluoromethyl)phenyl]-4-methylbenzamide
|
I609115-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-N-[3-imidazol-1-yl-5-(trifluoromethyl)phenyl]-4-methylbenzamide
|
I609115-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
15-[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one
|
I609011-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
15-[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one
|
I609011-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
3-(2-imidazo[1,2-a]pyrazin-5-ylethynyl)-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide
|
I608982-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
3-(2-imidazo[1,2-a]pyrazin-5-ylethynyl)-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide
|
I608982-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
7-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-6-methyl-N-[3-(trifluoromethyl)phenyl]-1,2-benzoxazol-3-amine
|
I608896-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
7-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-6-methyl-N-[3-(trifluoromethyl)phenyl]-1,2-benzoxazol-3-amine
|
I608896-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
2-Iodoadenosine-5′-O-[(phosphonomethyl)phosphonic Acid]
|
I608755-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
2-Iodoadenosine-5′-O-[(phosphonomethyl)phosphonic Acid]
|
I608755-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
α5IA
|
I607520-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |